David Church is Professor of Precision Oncology and CRUK Senior Cancer Research Fellow at the Centre for Human Genetics, University of Oxford. He is also an Honorary Consultant Medical Oncologist at the Oxford Cancer Centre, and clinical lead for Lynch Syndrome across the Central and South GMSA (population 10.5m). In addition to leading a research group focused on colorectal and endometrial cancers, he leads the Oxford LynchVax group (working to develop a vaccine to prevent Lynch syndrome-associated cancer), and the Genomics England 100K Genomes Project endometrial cancer domain, and is a member of several clinical trial translational research groups including TransSCOT and TransPORTEC.